Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway | Oncogenesis
Colorectal Cancer – Treatments | Gastrointestinal Cancer
Cancers | Free Full-Text | Targeting BRAF and RAS in Colorectal Cancer
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches - ScienceDirect
Mutational spectra of KRAS, BRAF and the Wnt effector genes APC and... | Download Scientific Diagram
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
The implication of BRAF mutation in advanced colorectal cancer | Irish Journal of Medical Science (1971 -)
Frequencies of RAS/BRAFV600E mutation subtypes. N = 152 (KRAS Exon2... | Download Scientific Diagram
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram
Distribution of molecular alterations in RAS wild-type mCRC, according... | Download Scientific Diagram
Clinico-pathological features associated to BRAF-mutated colorectal cancers | Download Scientific Diagram
Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram
BRAF Mutation and Its Importance in Colorectal Cancer | IntechOpen
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram
Factors affecting treatment selection in RAS/BRAF wild-type... | Download Scientific Diagram
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
IJMS | Free Full-Text | BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY
